Pressure BioSciences's Total Assets for the quarter that ended in Jun. 2024 was $6.88 Mil.
During the past 12 months, Pressure BioSciences's average Total Assets Growth Rate was 315.80% per year.
During the past 3 years, the average Total Assets Growth Rate was -24.90% per year.
During the past 5 years, the average Total Assets Growth Rate was -10.30% per year.
During the past 10 years, the average Total Assets Growth Rate was 3.20% per year.
During the past 13 years, Pressure BioSciences's highest 3-Year average Total Assets Growth Rate was 28.20%. The lowest was -42.70%. And the median was -5.70%.
The historical data trend for Pressure BioSciences's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Pressure BioSciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pressure BioSciences (OTCPK:PBIO) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Jun. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Pressure BioSciences's Asset Turnover for the quarter that ended in Jun. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Pressure BioSciences Total Assets Related Terms
Thank you for viewing the detailed overview of Pressure BioSciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBIO has been successfully added to your 